Why is Rossari Biotech falling/rising?

As of 01-Sep, Rossari Biotech Ltd is currently priced at 621.30, reflecting an increase of 3.2 (0.52%). The stock has been gaining for the last two days, with a total return of 0.7% during this period. However, it has underperformed its sector by 0.28% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 0.90%, and it has experienced significant underperformance over longer periods, with a year-to-date return of -21.12% and a one-year return of -29.76%. Despite a low debt-to-equity ratio and attractive valuation metrics, the stock's profits have fallen by 1% over the past year, contributing to its negative performance.
Broader market context shows that the Sensex has declined by 1.56% over the past week, while Rossari Biotech has outperformed the benchmark slightly in this timeframe. However, the stock has consistently underperformed against the benchmark over the last three years, generating negative returns compared to the BSE500 in each of the last three annual periods. The high institutional holdings at 21.32% suggest that knowledgeable investors are involved, but the flat results reported on June 25 and the lowest return on capital employed (ROCE) at 14.46% raise concerns about the company's financial health, influencing investor sentiment negatively.